Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-12-05

FDA Approved: ESZOPICLONE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for eszopiclone. This action represents a supplemental approval for the insomnia medicati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eszopiclone (eszopiclone)

Snippet

SUPPL AP for ESZOPICLONE (ESZOPICLONE)